2011
DOI: 10.1016/j.molstruc.2011.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Supramolecular structure of unnatural nucleobases: Revised structure of (2:1) 6-methylisocytosinium dihydrogen monophosphate adduct

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 41 publications
1
20
0
Order By: Relevance
“…1994), MECXUP (Tutughamiarso & Egert, 2012), MINVIP01 (Portalone & Irrera, 2011), OQURAU and OQUREY (Gerhardt et al, 2011), QOBCIV (Radhakrishnan et al, 2014) and ZERMIS (Toledo et al, 1995)]. The same kind of triple hydrogen-bond motif seen in Fig.…”
Section: Figurementioning
confidence: 69%
“…1994), MECXUP (Tutughamiarso & Egert, 2012), MINVIP01 (Portalone & Irrera, 2011), OQURAU and OQUREY (Gerhardt et al, 2011), QOBCIV (Radhakrishnan et al, 2014) and ZERMIS (Toledo et al, 1995)]. The same kind of triple hydrogen-bond motif seen in Fig.…”
Section: Figurementioning
confidence: 69%
“…Data collection: CrysAlis CCD (Oxford Diffraction, 2006); cell refinement: CrysAlis CCD; data reduction: CrysAlis RED (Oxford Diffraction, 2006); program(s) used to solve structure: SIR97 (Altomare et al, 1999); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012). For some time now, we have studied proton-transfer adducts containing molecules of biological interest (Portalone, 2011a;Portalone & Irrera, 2011). In this context, benzamidine derivatives, which have shown strong biological and pharmacological activity (Powers & Harper, 1999), have been used in our group as bricks for supramolecular construction (Portalone, 2010(Portalone, , 2011b(Portalone, , 2012.…”
Section: Methodsmentioning
confidence: 99%
“…For the biological and pharmacological relevance of benzamidine, see: Powers & Harper (1999). For structural analysis of proton-transfer adducts containing molecules of biological interest, see : Portalone, (2011a); Portalone & Irrera (2011). For supramolecular association in proton-transfer adducts containing benzamidinium cations, see; Portalone (2010Portalone ( , 2011bPortalone ( , 2012; Irrera et al (2012); Irrera & Portalone (2012a,b,c).…”
Section: Related Literaturementioning
confidence: 99%
“…For the biological and pharmacological relevance of benzamidine, see: Powers & Harper (1999); Grzesiak et al (2000). For structural analysis of proton-transfer adducts containing molecules of biological interest, see: Portalone (2011a); Portalone & Irrera (2011). For the supramolecular association in proton-transfer adducts containing benzamidinium cations, see: Portalone (2010Portalone ( , 2011bPortalone ( , 2012; ; .…”
Section: Related Literaturementioning
confidence: 99%